---
figid: PMC3580541__ar4071-5
figtitle: TRAF6 and TRAF2/5 signaling pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3580541
filename: ar4071-5.jpg
figlink: /pmc/articles/PMC3580541/figure/F5/
number: F5
caption: TRAF6 and TRAF2/5 signaling pathways. (a) The endogenous TRAF6 and TRAF2/5
  signaling pathways and post-translational modifications. (b) The presence of the
  psoriatic arthritis-associated single-nucleotide polymorphism (SNP) (rs33980500)
  could affect the proteins downstream of Act1. The decrease in TRAF6 binding could
  result in an increase in the TRAF2/5 signaling pathway and this in turn may lead
  to increased CXCL1 mRNA and protein expression. Act1, nuclear factor-kappa-B activator
  1; ASF, alternative splicing factor; IKK, IkB kinase; IL-17, interleukin-17; IL-17R,
  interleukin-17 receptor; NF-κB, nuclear factor-kappa-B; TAB, transforming growth
  factor-beta-activated kinase 1 (TAK1)-binding protein; TAK1, transforming growth
  factor-beta-activated kinase 1; TRAF6, tumor necrosis factor receptor-associated
  factor 6.
papertitle: New insight into the functions of the interleukin-17 receptor adaptor
  protein Act1 in psoriatic arthritis.
reftext: Matthew S Doyle, et al. Arthritis Res Ther. 2012;14(5):226-226.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.911499
figid_alias: PMC3580541__F5
figtype: Figure
redirect_from: /figures/PMC3580541__F5
ndex: a1d6f4a7-ded9-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3580541__ar4071-5.html
  '@type': Dataset
  description: TRAF6 and TRAF2/5 signaling pathways. (a) The endogenous TRAF6 and
    TRAF2/5 signaling pathways and post-translational modifications. (b) The presence
    of the psoriatic arthritis-associated single-nucleotide polymorphism (SNP) (rs33980500)
    could affect the proteins downstream of Act1. The decrease in TRAF6 binding could
    result in an increase in the TRAF2/5 signaling pathway and this in turn may lead
    to increased CXCL1 mRNA and protein expression. Act1, nuclear factor-kappa-B activator
    1; ASF, alternative splicing factor; IKK, IkB kinase; IL-17, interleukin-17; IL-17R,
    interleukin-17 receptor; NF-κB, nuclear factor-kappa-B; TAB, transforming growth
    factor-beta-activated kinase 1 (TAK1)-binding protein; TAK1, transforming growth
    factor-beta-activated kinase 1; TRAF6, tumor necrosis factor receptor-associated
    factor 6.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TRAF3IP2
  - RPL17
  - TPGS2
  - IGKV2D-14
  - AR
  - IL17A
  - TRAF6
  - TRAF2
  - TANK
  - TRAF5
  - ARSF
  - PSMD4
  - SRSF1
  - THRA
  - TRA
  - TRAC
  - IK
---
